임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
56건 표시
- 2상모집 예정· Advanced or Metastatic Solid TumourSCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates
협력: 길리어드
- 2상모집 중· Small Cell Lung Cancer ( SCLC )Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
협력: 길리어드
- 2상모집 중· Advanced Microsatellite Stable Colorectal CancerStudy of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
리드: 길리어드
- 2상모집 중· Hematopoietic and Lymphatic System NeoplasmRemdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
협력: 길리어드
- 2상모집 중· Squamous Cell Carcinoma of Head and NeckA Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
협력: 길리어드
- 2상모집 중· Salivary Gland CancerSacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
협력: 길리어드
- 2상모집 중· Locally Advanced Gastric AdenocarcinomaZimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer
협력: 길리어드
- 2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaStudy of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01
리드: 길리어드
- 2상모집 예정· Bladder CancerBladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer
협력: 길리어드
- 2상모집 중· Urothelial CarcinomaAdjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence
협력: 길리어드
- 2상모집 중단 (진행 중)· Pre-Exposure Prophylaxis of HIV InfectionStudy of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)
리드: 길리어드
- 2상모집 중· Esophageal Squamous Cell CarcinomaSacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
협력: 길리어드
- 2상모집 중단 (진행 중)· Ulcerative ColitisStudy of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 길리어드
- 2상모집 중단 (진행 중)· Relapsed/Refractory Mantle Cell LymphomaStudy of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
협력: 길리어드
- 2상모집 중단 (진행 중)· Biliary Tract CarcinomaStudy of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
협력: 길리어드
- 2상모집 중단 (진행 중)· Ovarian CarcinomaA Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
협력: 길리어드
- 2상모집 중단 (진행 중)· Pre-Exposure Prophylaxis of HIV InfectionStudy of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
리드: 길리어드
- 2상모집 중· Ulcerative ColitisStudy of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 길리어드
- 2상모집 중단 (진행 중)· Her 2 Positive Breast CancerA Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
협력: 길리어드
- 2상모집 중단 (진행 중)· Pre-Exposure Prophylaxis of HIV InfectionStudy of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
리드: 길리어드
- 2상모집 중· Cervical CancerA Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
협력: 길리어드
- 2상모집 중단 (진행 중)· Lung CancerStudy of Novel Treatment Combinations in Patients With Lung Cancer
리드: 길리어드
- 2상모집 중단 (진행 중)· Advanced Non-Small Cell Lung CancerStudy With Various Immunotherapy Treatments in Participants With Lung Cancer
리드: 길리어드
- 2상모집 중단 (진행 중)· Locally Advanced or Metastatic Urothelial CarcinomaA Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
협력: 길리어드
- 2상모집 중단 (진행 중)· Multiple MyelomaStudy of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
협력: 길리어드
- 2상모집 중단 (진행 중)· Gastrointestinal Tract MalignanciesA Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
협력: 길리어드
- 2상모집 중단 (진행 중)· Non-small Cell Lung CancerStudy of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
리드: 길리어드 · 협력: 머크(MSD)
- 2상모집 중단 (진행 중)· HIV-1 InfectionStudy Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV
리드: 길리어드 · 협력: 머크(MSD)
- 2상모집 중단 (진행 중)· Anatomic Stage IV Breast Cancer AJCC v8Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases
협력: 길리어드
- 2상모집 중단 (진행 중)· Non Small Cell Lung CancerStudy Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
협력: 길리어드
- 2상모집 중단 (진행 중)· Metastatic Triple-negative Breast CancerStudy of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments
리드: 길리어드
- 2상모집 중단 (진행 중)· Invasive Breast CancerSacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
협력: 길리어드, 머크(MSD)
- 2상모집 중단 (진행 중)· Endometrial CarcinomaA Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
협력: 길리어드
- 2상모집 중단 (진행 중)· Metastatic Solid TumorStudy of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
리드: 길리어드
- 2상모집 중단 (진행 중)· Stage III Breast CancerAvelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
협력: 길리어드, 화이자
- 2상모집 중단 (진행 중)· Prostate CancerSacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
협력: 길리어드
- 2상모집 중· Metastatic Urothelial CancerStudy of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
리드: 길리어드
- 2상모집 중단 (진행 중)· Chronic Hepatitis BStudy of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
리드: 길리어드
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.